These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36520180)

  • 21. Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps.
    Yin JD; Song LR; Lu HC; Zheng X
    World J Gastroenterol; 2020 May; 26(17):2082-2096. PubMed ID: 32536776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents.
    Barendregt AM; van Gulik EC; Lavini C; Nusman CM; van den Berg JM; Schonenberg-Meinema D; Dolman KM; Kuijpers TW; Hemke R; Maas M
    Eur Radiol; 2017 Nov; 27(11):4889-4899. PubMed ID: 28608162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC).
    Xu L; Tian J; Liu Y; Li C
    J Magn Reson Imaging; 2014 Jul; 40(1):200-5. PubMed ID: 24923480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.
    Choi EJ; Youk JH; Choi H; Song JS
    J Magn Reson Imaging; 2020 Feb; 51(2):615-626. PubMed ID: 31313393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion kurtosis imaging in identifying the malignancy of lymph nodes during the primary staging of rectal cancer.
    Yu J; Dai X; Zou HH; Song JC; Li Y; Shi HB; Xu Q; Shen H
    Colorectal Dis; 2018 Feb; 20(2):116-125. PubMed ID: 28772347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The application of apparent diffusion coefficients derived from intratumoral and peritumoral zones for assessing pathologic prognostic factors in rectal cancer.
    Yuan Y; Chen XL; Li ZL; Chen GW; Liu H; Liu YS; Pang MH; Liu SY; Pu H; Li H
    Eur Radiol; 2022 Aug; 32(8):5106-5118. PubMed ID: 35320412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of apparent diffusion coefficient values derived from diffusion-weighted imaging for assessing different sized metastatic lymph nodes in cervical cancers.
    Zhang A; Song J; Ma Z; Chen T
    Acta Radiol; 2020 Jun; 61(6):848-855. PubMed ID: 31615267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to manage type 2 curve dilemma in dynamic contrast-enhanced magnetic resonance imaging of the breast: diffusion-weighted imaging or early phase enhancement kinetics?
    Ulu Öztürk F; Tezcan Ş; Uslu N
    Acta Radiol; 2024 Apr; 65(4):341-349. PubMed ID: 38193154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of Benign From Malignant Sinonasal Masses Using Diffusion Weighted Imaging and Dynamic Contrast Enhanced Magnetic Resonance Imaging.
    Daga R; Kumar J; Pradhan G; Meher R; Malhotra V; Khurana N
    Am J Rhinol Allergy; 2022 Mar; 36(2):207-215. PubMed ID: 34486401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
    Youk JH; Son EJ; Chung J; Kim JA; Kim EK
    Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and reproducibility of T2 mapping and DWI for identifying malignant lymph nodes in rectal cancer.
    Ge YX; Hu SD; Wang Z; Guan RP; Zhou XY; Gao QZ; Yan G
    Eur Radiol; 2021 May; 31(5):3347-3354. PubMed ID: 33185752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting tumor deposits in patients with rectal cancer: Using the models of multiple mathematical parameters derived from diffusion-weighted imaging.
    Hong Y; Song G; Jia Y; Wu R; He R; Li A
    Eur J Radiol; 2022 Dec; 157():110573. PubMed ID: 36347167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy.
    Reynolds HM; Tadimalla S; Wang YF; Montazerolghaem M; Sun Y; Williams S; Mitchell C; Finnegan ME; Murphy DG; Haworth A
    Cancer Imaging; 2022 Dec; 22(1):71. PubMed ID: 36536464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?
    Li X; Wang H; Gao J; Jiang L; Chen M
    Quant Imaging Med Surg; 2023 Oct; 13(10):7092-7104. PubMed ID: 37869329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer.
    Alberda WJ; Dassen HP; Dwarkasing RS; Willemssen FE; van der Pool AE; de Wilt JH; Burger JW; Verhoef C
    Int J Colorectal Dis; 2013 Apr; 28(4):573-80. PubMed ID: 23001160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of MRI and diffusion-weighted imaging in diagnosing normal-sized pelvic lymph nodes metastases in patients with cervical cancer.
    Song Q; Yu Y; Zhang X; Zhu Y; Luo Y; Yu T; Sun J; Liu F; Dong Y
    Br J Radiol; 2022 Sep; 95(1138):20200203. PubMed ID: 33095657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.